Drugs / Donor Lymphocyte Infusion (DLI)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00984165 | Jan 2010 → Jan 2013 | Hodgkins lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, plasma cell myeloma | National Cancer Institute (NCI) | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Donor Lymphocyte Infusion (DLI) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00984165 ↗ |